These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 34402547)

  • 21. Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response.
    Corma-Gómez A; Macías J; Morano L; Rivero A; Téllez F; Ríos MJ; Santos M; Serrano M; Palacios R; Merino D; Real LM; De Los Santos I; Vera-Méndez FJ; Galindo MJ; Pineda JA;
    Clin Infect Dis; 2021 Mar; 72(5):e96-e102. PubMed ID: 33211801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of direct-acting antiviral treatment on reducing mortality among Medicare beneficiaries with HIV and HCV coinfection.
    Yin X; Kong L; Du P; Jung J
    AIDS Care; 2022 Oct; 34(10):1330-1337. PubMed ID: 34581640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy.
    Milazzo L; Lai A; Calvi E; Ronzi P; Micheli V; Binda F; Ridolfo AL; Gervasoni C; Galli M; Antinori S; Sollima S
    HIV Med; 2017 Apr; 18(4):284-291. PubMed ID: 27477612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials.
    Shafran SD
    Clin Infect Dis; 2015 Oct; 61(7):1127-34. PubMed ID: 26060286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
    Pradat P; Pugliese P; Poizot-Martin I; Valantin MA; Cuzin L; Reynes J; Billaud E; Huleux T; Bani-Sadr F; Rey D; Frésard A; Jacomet C; Duvivier C; Cheret A; Hustache-Mathieu L; Hoen B; Cabié A; Cotte L;
    J Infect; 2017 Sep; 75(3):234-241. PubMed ID: 28579302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States.
    Chen PH; Yenokyan K; Fojo AT; Hutton HE; Lesko CR; McCaul ME; Yang C; Cachay ER; Crane HM; Jacobson JM; Kim HN; Kitahata MM; Mayer KH; Moore RD; Napravnik S; Saag M; Lau B; Chander G
    Drug Alcohol Depend; 2022 Dec; 241():109673. PubMed ID: 36332596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data).
    Barré T; Mercié P; Lions C; Miailhes P; Zucman D; Aumaître H; Esterle L; Sogni P; Carrieri P; Salmon-Céron D; Marcellin F;
    AIDS Res Ther; 2022 Mar; 19(1):15. PubMed ID: 35292069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Has Increased Rollout of Direct Acting Antiviral Therapy Decreased the Burden of Late Presentation and Advanced Liver Disease in Patients Starting Hepatitis C Virus Therapy in Germany?
    Bischoff J; Boesecke C; Ingiliz P; Berger F; Simon KG; Lutz T; Schewe CK; Schulze Zur Wiesch J; Hueppe D; Christensen S; Mauss S; Baumgarten A; Rockstroh JK;
    J Clin Gastroenterol; 2020 Feb; 54(2):192-199. PubMed ID: 30789853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DAA-mediated HCV cure reduces HIV DNA levels in HCV/HIV coinfected people.
    Gobran ST; Pagliuzza A; Khedr O; Fert A; Chomont N; Bruneau J; Klein MB; Ancuta P; Shoukry NH
    J Virol; 2023 Dec; 97(12):e0110523. PubMed ID: 38051044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV.
    Willis SJ; Kim HN; Achenbach CJ; Cachay ER; Christopoulos KA; Crane HM; Franco RA; Hurt CB; Kitahata MM; Moore RD; Silverberg MJ; Tien PC; Westreich D; Marcus JL
    HIV Med; 2022 Jul; 23(6):620-628. PubMed ID: 34951105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapy.
    Taylor LE; Swan T; Matthews GV
    Clin Infect Dis; 2013 Aug; 57 Suppl 2(Suppl 2):S118-24. PubMed ID: 23884059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort.
    Piroth L; Wittkop L; Lacombe K; Rosenthal E; Gilbert C; Miailhes P; Carrieri P; Chas J; Poizot-Martin I; Gervais A; Dominguez S; Neau D; Zucman D; Billaud E; Morlat P; Aumaitre H; Lascoux-Combe C; Simon A; Bouchaud O; Teicher E; Bani-Sadr F; Alric L; Vittecoq D; Boué F; Duvivier C; Valantin MA; Esterle L; Dabis F; Sogni P; Salmon D;
    J Hepatol; 2017 Jul; 67(1):23-31. PubMed ID: 28235612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk of hepatitis C virus recurrence in hepatitis C virus-infected patients treated with direct-acting antivirals after achieving a sustained virological response: A comprehensive analysis.
    Huang P; Wang Y; Yue M; Ge Z; Xia X; Jeyarajan AJ; Holmes JA; Yu R; Zhu C; Yang S; Lin W; Chung RT
    Liver Int; 2021 Oct; 41(10):2341-2357. PubMed ID: 34051040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.
    Smolders EJ; Smit C; de Kanter C; Dofferhoff A; Arends JE; Brinkman K; Rijnders B; van der Valk M; Reiss P; Burger DM;
    HIV Med; 2018 Mar; 19(3):216-226. PubMed ID: 29194939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.
    Lo Re V; Volk J; Newcomb CW; Yang YX; Freeman CP; Hennessy S; Kostman JR; Tebas P; Leonard MB; Localio AR
    Hepatology; 2012 Nov; 56(5):1688-98. PubMed ID: 22619086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+ T-cell recovery in HIV/hepatitis C co-infected patients following successful hepatitis C treatment.
    Ryscavage P; Hussien S; Seung H; Hynicka L
    HIV Med; 2024 May; 25(5):622-627. PubMed ID: 38273652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological effects of direct-acting antiviral treatment for Hepatitis C virus subjects: A systematic review.
    Santos-Lima C; Souza-Marques B; Vieira F; Isabel Schinoni M; Quarantini LC; Abreu N
    J Viral Hepat; 2021 Dec; 28(12):1672-1682. PubMed ID: 34320255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).
    Marcellin F; Di Beo V; Aumaitre H; Mora M; Wittkop L; Duvivier C; Protopopescu C; Lacombe K; Esterle L; Berenger C; Gilbert C; Bouchaud O; Poizot-Martin I; Sogni P; Salmon-Ceron D; Carrieri P;
    J Hepatol; 2020 Mar; 72(3):588-591. PubMed ID: 31924411
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy, Tolerability, and Compliance of Direct Acting Antivirals in Patients with HIV and Hepatitis C Coinfection: A Real-Life Experience.
    Mishra S; Taneja S; De A; Verma N; Premkumar M; Naidu GSRSNK; Sharma A; Duseja A; Dhiman RK; Singh V
    AIDS Res Hum Retroviruses; 2023 Sep; 39(9):453-458. PubMed ID: 36511384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reply to: "Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)".
    Evon DM; Sarkar S; Amador J; Lok AS; Sterling RK; Stewart PW; Reeve BB; Serper M; Reau N; Reddy KR; Di Bisceglie AM; Nelson DR; Golin CE; Lim JK; Fried MW
    J Hepatol; 2020 Mar; 72(3):592-593. PubMed ID: 31889556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.